In NPM1/FLT3 co-mutated AML, concurrent menin and FLT3 inhibition dismantles cooperative HOX-dependent fitness while suppressing mitogenic drive, offering a chemo-sparing strategy (Carter et al., 2023). Here, NPM1 is linked to acute myeloid leukemia.